Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
IPO
Biotech
RayzeBio plans IPO to push 'pipeline-in-a-product' through ph. 3
With its lead radiotherapeutic in phase 3 trials, the biotech is eyeing up an IPO to take its plans forward.
James Waldron
Aug 25, 2023 7:09am
A 'painful reset' for biotech brings small checks, green shoots
Aug 2, 2023 10:29am
Affini-T plans to go public in 2024
Jul 25, 2023 2:42pm
Turnstone turns fortunes around with $80M IPO haul
Jul 21, 2023 9:25am
Neumora installs new CEO ahead of pivotal depression trials
Jul 18, 2023 6:30am
Apogee, Sagimet overshoot IPO expectations as they reach Nasdaq
Jul 14, 2023 8:55am
